UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
6-K/A
Amendment No. 1
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of August 2025
Commission
File Number: 001-40678
EUDA
Health Holdings Limited
(Exact
Name of Registrant as Specified in its Charter)
60
Kaki Bukit Place, #03-01
Eunos
Techpark
Singapore
415979
(Address
of Principal Executive Offices and Zip Code)
Registrant’s
telephone number, including area code: +65-6327-1110
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form
40-F ☐
As
disclosed on Form 6-K with the Securities and Exchange Commission (the “Commission”) on August 6, 2025 by
EUDA Health Holdings Limited (“EUDA” or the “Company”), the Company entered into a convertible promissory
note purchase agreement dated as of August 1, 2025 (the “Purchase Agreement”) with an institutional investor (the “Purchaser”)
to purchase one or more convertible promissory notes (the “Notes”) in an aggregate amount not to exceed $10,000,000. Shares
to be issued upon conversion of the Notes will be issued pursuant to a prospectus supplement to be filed with the Commission on
or around August 8, 2025, and the prospectus included in the Company’s Registration Statement on Form F-3 (File No. 333-282723),
which was filed with the Securities and Exchange Commission on October 18, 2024 and declared effective on November 4, 2024. The Company
is filing with this Current Report an opinion of counsel in connection with these shares.
This
Report on Form 6-K shall not constitute an offer to sell or the solicitation of an offer to buy the ordinary shares (or the Notes) nor
shall there be any sale of the ordinary shares (or the Notes) in any state or jurisdiction in which such offer, solicitation or sale
would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
Exhibits
| 5.1 |
Opinion of Conyers Dill & Pearman Pte. Ltd. |
| 23.1 |
Consent of Conyers Dill & Pearman Pte. Ltd. (included in Exhibit 5.1) |
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, hereunto duly authorized.
| Dated:
August 8, 2025 |
|
|
| |
|
| |
EUDA
Health Holdings Limited |
| |
|
|
| |
By: |
/s/
Vivian Tay |
| |
Name: |
Vivian
Tay |
| |
Title: |
Interim
Chief Financial Officer |
